1Fischer G,Stieh J, Uebing A, et al. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients[J]. Heart ,2003,89(2): 199-204.
2Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years[J]. Eur Heart J, 2003,24(2):
3Brandt RR, Neumann T, Neuzner J, et al. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents[J]. J Am Soc Echocardiogr,
4Sievert H, Krumsdorf U. Transcatheter closure of intracardiac shunts[J]. Z Kardiol, 2002,91 (Suppl 3): 77-83.
9Fischer G, Apostolopoulou SC, Rammos S, et al. The Amplatzer Membranous VSD Occluder and the vulnerability of the atrioventricular conduction system [ J ]. Cardiol Young, 2007, 17 ( 5 ) : 499-504.
10Pinto R J, Dalvi BV, Shanna S. Transcaeter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder : preliminary experience with 18-month follow up [ J ] . Catheter Cardiovasc Interv, 2006, 68 ( 1 ) : 145-152.
